122 related articles for article (PubMed ID: 31550148)
1. Luminescent Gold(I) Complexes of 1-Pyridyl-3-anthracenylchalcone Inducing Apoptosis in Colon Carcinoma Cells and Antivascular Effects.
González JJ; Ortega E; Rothemund M; Gold M; Vicente C; de Haro C; Bautista D; Schobert R; Ruiz J
Inorg Chem; 2019 Oct; 58(19):12954-12963. PubMed ID: 31550148
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
[TBL] [Abstract][Full Text] [Related]
3. A Multitarget Gold(I) Complex Induces Cytotoxicity Related to Aneuploidy in HCT-116 Colorectal Carcinoma Cells.
Zhang JJ; Abu El Maaty MA; Hoffmeister H; Schmidt C; Muenzner JK; Schobert R; Wölfl S; Ott I
Angew Chem Int Ed Engl; 2020 Sep; 59(38):16795-16800. PubMed ID: 32529715
[TBL] [Abstract][Full Text] [Related]
4. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L
Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487
[TBL] [Abstract][Full Text] [Related]
6. New selective thiolate gold(i) complexes inhibit the proliferation of different human cancer cells and induce apoptosis in primary cultures of mouse colon tumors.
Abas E; Pena-Martinez R; Aguirre-Ramírez D; Rodriguez-Dieguez A; Laguna M; Grasa L
Dalton Trans; 2020 Feb; 49(6):1915-1927. PubMed ID: 31971194
[TBL] [Abstract][Full Text] [Related]
7. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Gold(I) Complexes Containing Cinnamide: In Vitro Evaluation of Anticancer Activity in 2D and 3D Spheroidal Models of Melanoma and In Vivo Angiogenesis.
Ganga Reddy V; Srinivasa Reddy T; Privér SH; Bai Y; Mishra S; Wlodkowic D; Mirzadeh N; Bhargava S
Inorg Chem; 2019 May; 58(9):5988-5999. PubMed ID: 30985125
[TBL] [Abstract][Full Text] [Related]
9. Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
Canela MD; Noppen S; Bueno O; Prota AE; Bargsten K; Sáez-Calvo G; Jimeno ML; Benkheil M; Ribatti D; Velázquez S; Camarasa MJ; Díaz JF; Steinmetz MO; Priego EM; Pérez-Pérez MJ; Liekens S
Oncotarget; 2017 Feb; 8(9):14325-14342. PubMed ID: 27224920
[TBL] [Abstract][Full Text] [Related]
10. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity.
Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ
Eur J Med Chem; 2003 Feb; 38(2):179-87. PubMed ID: 12620662
[TBL] [Abstract][Full Text] [Related]
13. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
14. Potential of Gold Candidates against Human Colon Cancer.
Abbasi M; Yaqoob M; Haque RA; Iqbal MA
Mini Rev Med Chem; 2021; 21(1):69-78. PubMed ID: 32767935
[TBL] [Abstract][Full Text] [Related]
15. In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.
Pantelić N; Stanojković TP; Zmejkovski BB; Sabo TJ; Kaluđerović GN
Eur J Med Chem; 2015 Jan; 90():766-74. PubMed ID: 25528331
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
[TBL] [Abstract][Full Text] [Related]
17. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Influence of the Aromaticity on the Anticancer and Antivascular Activities of Organoplatinum(II) Complexes.
Zamora A; Pérez SA; Rothemund M; Rodríguez V; Schobert R; Janiak C; Ruiz J
Chemistry; 2017 Apr; 23(23):5614-5625. PubMed ID: 28278370
[TBL] [Abstract][Full Text] [Related]
19. Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold.
Schmitt F; Donnelly K; Muenzner JK; Rehm T; Novohradsky V; Brabec V; Kasparkova J; Albrecht M; Schobert R; Mueller T
J Inorg Biochem; 2016 Oct; 163():221-228. PubMed ID: 27491634
[TBL] [Abstract][Full Text] [Related]
20. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
